Stock comparison
LeMaitre Vascular
Tenet Healthcare
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
THC
Tenet Healthcare
Market cap
$14.97B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | THC | Winner |
|---|---|---|---|
| Warren Buffett | 77B | 55C | LMAT |
| Benjamin Graham | 89A | 73B | LMAT |
| Philip Fisher | 81C | 47D | LMAT |
| Peter Lynch | 67B | 41D | LMAT |
| Joel Greenblatt | 56D | 32F | LMAT |
| Charlie Munger | 68D | 50D | LMAT |
| Terry Smith | 69D | 52D | LMAT |
Side-by-side metrics
| Metric | LMAT | THC |
|---|---|---|
| Market cap | $2.23B | $14.97B |
| P/E (TTM) | 37.1x | 9.8x |
| EV/EBIT | 36.6x | 7.8x |
| ROIC (TTM) | 9.43% | 11.53% |
| Gross margin | 72.39% | 42.76% |
| Net margin | 24.35% | 7.94% |
| Revenue CAGR 5y | 12.75% | 2.26% |
| EPS CAGR 5y | 19.04% | 16.24% |
| Debt / Equity | 0.5x | 2.7x |
| Dividend yield | 0.84% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- Dividend yield0.84%vs 0.0%+100%
- Debt / Equity0.5xvs 2.7x+83%
- Revenue CAGR 5y12.75%vs 2.26%+82%
- Net margin24.35%vs 7.94%+67%
THC leads on
- Market cap$14.97Bvs $2.23B+85%
- EV/EBIT7.8xvs 36.6x+79%
- P/E (TTM)9.8xvs 37.1x+74%
- ROIC (TTM)11.53%vs 9.43%+18%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.